MeSH Browser

MeSH Supplementary: fostamatinib
Unique ID: C523665
RDF Unique Identifier: http://id.nlm.nih.gov/mesh/C523665
Entry Term(s): (6-((5-fluoro-2-((3,4,5-trimethoxyphenyl)amino)pyrimidin-4-yl)amino)-2,2-dimethyl-3-oxo-2,3-dihydro-4H-pyrido(3,2-b)-1,4-oxazin-4-yl)methyl disodium phosphate hexahydrate; 2H-pyrido(3,2-b)-1,4-oxazin-3(4H)-one, 6-((5-fluoro-2-((3,4,5-trimethoxyphenyl)amino)-4-pyrimidinyl)amino)-2,2-dimethyl-4-((phosphonooxy)methyl)-; 2H-pyrido(3,2-b)-1,4-oxazin-3(4H)-one, 6-((5-fluoro-2-((3,4,5-trimethoxyphenyl)amino)-4-pyrimidinyl)amino)-2,2-dimethyl-4-((phosphonooxy)methyl)-, sodium salt (1:2); R-788 free acid; R-788 sodium; R-788 sodium anhydrous; R-788 sodium hydrate; R-935788 free acid; R-935788 sodium anhydrous; R-935788 sodium hydrate; R788 free acid; R788 sodium; R788 sodium anhydrous; R788 sodium hydrate; R935788 free acid; R935788 sodium anhydrous; R935788 sodium hydrate; Tavalisse; fostamatinib disodium; fostamatinib disodium anhydrous; fostamatinib disodium hydrate; fostamatinib disodium salt hexahydrate
Registry Numbers: SQ8A3S5101; 0; 86EEZ49YVB; X9417132K8
Related Numbers: 86EEZ49YVB; X9417132K8
Heading Mapped to: *Aminopyridines; *Morpholines; *Pyrimidines
Frequency: 135
Note: a spleen tyrosine kinase (Syk) inhibitor, metabolized to R406
Source: Clin Immunol 2007 Sep;124(3):244-57
Date of Entry: 2007/10/22
Revision Date: 2021/10/21

Concept UI: M0514674
Registry Numbers: 0
Terms: R788 free acid Preferred Term
Term UI T001113307
Date10/21/2021
LexicalTag LAB
ThesaurusID FDA SRS (2017); R-788 free acid
Term UI T001113309
Date10/21/2021
LexicalTag LAB
ThesaurusID FDA SRS (2017); R935788 free acid
Term UI T001113310
Date10/21/2021
LexicalTag LAB
ThesaurusID FDA SRS (2017); R-935788 free acid
Term UI T001113311
Date10/21/2021
LexicalTag LAB
ThesaurusID FDA SRS (2017)

fostamatinib MeSH Supplementary Concept Data 2025